VVOS - Vivos Therapeutics EPS misses by $0.01 beats on revenue August, 12 2021 04:37 PM Vivos Therapeutics Inc. Vivos Therapeutics (NASDAQ:VVOS): Q2 GAAP EPS of -$0.19 misses by $0.01. Revenue of $4.5M beats by $0.9M. Press Release For further details see: Vivos Therapeutics EPS misses by $0.01, beats on revenue